Crossmark

Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation

Crossref DOI link: https://doi.org/10.1186/s12967-024-04875-8

Published Online: 2024-02-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ryu, Ji-yeon

Jang, Eui Hwa

Lee, JiYong

Kim, Jung-Hwan

Youn, Young-Nam
Funding

Funding for this research was provided by:

Korea Health Industry Development Institute (HI18C1237)

Ministry of Education (NRF-2022R1I1A1A01069432)

Ministry of Science and ICT, South Korea (2022R1F1A107090312)
License Information

Text and Data Mining valid from 2024-02-16

Version of Record valid from 2024-02-16
More Information

Article History

Received: 14 September 2023

Accepted: 8 January 2024

First Online: 16 February 2024

Declarations

:

: This study was approved by the Institutional Animal Care and Use Committee of Yonsei University Health System (Approval No. 2022-0263).

: Not applicable.

: The authors have no competing interests to declare.

Document is current

Any future updates will be listed below